Meeting
2016 Genitourinary Cancers Symposium
Study of PSMA-targeted 18F-DCFPyL PET/CT in the evaluation of men with an elevated PSA following radical prostatectomy.
Authors
Michael A. Gorin
Johns Hopkins University School of Medicine, Baltimore, MD
Michael A. Gorin , Steven P. Rowe , Margarita Mana-ay , Zsolt Szabo , Edward M. Schaeffer , Phuoc T. Tran , Mohamad E. Allaf , Curtiland Deville , Steve Y. Cho , Kenneth J. Pienta , Martin G. Pomper , Ashley Ross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Clinical Trial Registration Number
NCT02523924
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 299)
DOI
10.1200/jco.2016.34.2_suppl.299
Abstract #
299
Poster Bd #
N4
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Detection of prostate cancer lesions using Gallium-68 PSMA-11 PET in men with biochemical recurrence following radical prostatectomy.
First Author: Adam J. Gadzinski
Poster
2024 ASCO Genitourinary Cancers Symposium
Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk of biochemical recurrence (BCR) after radical prostatectomy (RP) in the ongoing phase 3 PRIMORDIUM study.
First Author: Boris A. Hadaschik
Poster
2024 ASCO Genitourinary Cancers Symposium
Detection and delineation of intraprostatic lesions (IPLs) using multiparametric magnetic resonance imaging (mpMRI) and prostate specific membrane antigen positron emission tomography (PSMA PET) for patients with prostate cancer: A systematic review and meta-analysis.
First Author: Aneesh Dhar
Poster
2023 ASCO Genitourinary Cancers Symposium
Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy in recurrent prostate cancer.
First Author: Constantinos Zamboglou